BDBM161805 US9682976, 242
SMILES: COc1cc(cc(Nc2ncc(F)c(N[C@@H]3C[C@@H]4CCCN4C(C)(C)C3)n2)c1F)-n1nnnc1C
InChI Key: InChIKey=ISCXKFXOPIJVFT-CABCVRRESA-N
Data: 1 EC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Interleukin-2 (IL-2) (Homo sapiens (Human)) | BDBM161805 (US9682976, 242) | PDB MMDB KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <100 | n/a | n/a | n/a | n/a |
Rigel Pharmaceuticals, Inc. US Patent | Assay Description Primary T cell stimulation and IL2 ELISA: Human primary T cells (100,000 cells per well) were pre-incubated with or without test compound in Yssel... | US Patent US9682976 (2017) BindingDB Entry DOI: 10.7270/Q2DJ5CT2 | |||||||||||
More data for this Ligand-Target Pair |